A new proprietary analysis of cutting-edge Alzheimer's drugs finds growing excitement around experimental therapies targeting ...

A large health-record analysis found that glucosamine use was associated with a 25% higher likelihood of mild cognitive ...

Communities took part in the annual fundraising event to support local and global Alzheimer's programs ...

Researchers at Washington University School of Medicine in St. Louis have developed a potential antibody-based approach to ...

Researchers have uncovered a surprising immune-system switch in the brain that could open a new avenue in the fight the ...

Ultrahigh-performance liquid chromatography–tandem mass spectrometry (UHPLC–MS/MS) tracks blood metabolite changes after repetitive transcranial magnetic stimulation (rTMS)-cognitive training therapy.

Jeremy Scott told Newsweek he remembers having a strange experience at a Disney resort years before his diagnosis.

Two years is a fairly typical length of time for people with symptoms to receive a diagnosis of Alzheimer’s, even though ...

What can mathematics reveal about Alzheimer's disease? Mississippi State University associate professor Shantia Yarahmadian ...

Alzheimer’s disease (AD) is a heterogeneous disorder with multiple etiologies. Harnessing the immune system by blocking the programmed cell death receptor (PD)-1 pathway in an amyloid beta mouse model ...

The Detroit walk is the most popular and largest Walk to End Alzheimer’s in Michigan, drawing large Metro Detroit crowds ...